- Alzheimer’s disease is the most common form of dementia at a global level.
- Scientists say that more therapy options are needed for the disease.
- Researchers from Sanford Burnham Prebys Medical Discovery Institute in La Jolla, CA, believe common HIV medications may offer potential treatment opportunities for Alzheimer’s disease.
Researchers from Sanford Burnham Prebys Medical Discovery Institute in La Jolla, CA, have recently conducted a study which suggests that medications commonly used to treat HIV may also offer potential treatment opportunities for Alzheimer’s disease.
Their study paper appears in the journal Pharmaceuticals.
“Alzheimer’s disease is the most
“In addition to those afflicted, families, society, and our economy are severely impacted by Alzheimer’s disease,” Chun added.
According to him, “[currently] approved therapies [for Alzheimer’s] have marginal benefit — [they] are not cures nor truly disease-modifying — and can also negatively affect patient health.“
“New treatment options that work better with less health risk are needed,” said Chun.
Chun explained that his and his team’s study is based on
“Reverse transcriptase is a famous protein — a protein that can do things is called an ‘enzyme’ and reverse transcriptase is an enzyme — that can copy
RNA — the stuff that encodes proteins in our cells — back into DNA, a ‘reverse’ process from the usual ‘Central Dogma’ of…
Read the full article here
